Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CR845 in patients undergoing abdominal surgery
NCT02542384Phase 3Completed
- Sponsor
- Cara Therapeutics, Inc.
- Start
- Sep 2015
- Primary completion
- Apr 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of difelikefalin in postoperative pain (3 arms), sponsored by Cara Therapeutics, Inc. Primary endpoint: Change in Pain Intensity over time using the Numeric Rating Scale at 24 hours. Started Sep 2015; status: completed.
02
Drugs
difelikefalin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02542384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02542384.